| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.30B | 5.59B | 5.37B | 6.06B | 8.04B | 7.35B |
| Gross Profit | 1.35B | 1.32B | 1.41B | 1.57B | 2.33B | 2.28B |
| EBITDA | 622.83M | 593.33M | 588.92M | 491.94M | 668.98M | 913.71M |
| Net Income | 126.86M | 116.07M | 132.33M | 75.15M | 191.06M | 274.21M |
Balance Sheet | ||||||
| Total Assets | 6.69B | 6.89B | 7.11B | 6.95B | 8.98B | 8.74B |
| Cash, Cash Equivalents and Short-Term Investments | 1.61B | 1.64B | 1.59B | 1.97B | 2.45B | 1.76B |
| Total Debt | 885.79M | 1.26B | 1.24B | 847.71M | 1.89B | 1.40B |
| Total Liabilities | 1.84B | 2.12B | 2.32B | 1.93B | 3.54B | 3.34B |
| Stockholders Equity | 4.84B | 4.76B | 4.79B | 5.03B | 5.44B | 5.40B |
Cash Flow | ||||||
| Free Cash Flow | 65.78M | 213.69M | 173.08M | 780.78M | 639.76M | 561.60M |
| Operating Cash Flow | 829.30M | 508.97M | 388.74M | 1.03B | 931.50M | 749.76M |
| Investing Cash Flow | 2.23M | 603.22M | -1.04B | 883.29M | -1.57B | 497.45M |
| Financing Cash Flow | -1.64B | -336.61M | -23.69M | -1.30B | -33.54M | -663.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$18.71B | 10.91 | 14.30% | 5.87% | 6.88% | 11.98% | |
71 Outperform | HK$72.67B | 14.56 | 17.82% | 4.31% | 8.19% | -6.72% | |
67 Neutral | HK$2.33B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$1.73B | 2.40 | 2.58% | 9.71% | -7.47% | -33.28% | |
60 Neutral | HK$1.04B | 5.21 | 5.79% | 6.04% | -1.81% | -2.23% | |
59 Neutral | HK$1.58B | 6.53 | 4.73% | 8.06% | -2.44% | -5.98% |